"luminal progenitor cells" trang 2 - tải miễn phí từ tailieunhanh
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
8    80    0
Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: A multicenter analysis

Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: A multicenter analysis
8    79    0
Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
9    90    0
Circulating microRNAs miR-331 and miR195 differentiate local luminal a from metastatic breast cancer

Circulating microRNAs miR-331 and miR195 differentiate local luminal a from metastatic breast cancer
10    80    0
BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
17    78    0
Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer

Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer
8    67    1
Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes

Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes
14    62    1
Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
13    40    1
IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells

IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells
11    31    1
The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype
17    37    1
Monitoring therapeutic efficacy of sunitinib using [18F]FDG and [18F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma

Monitoring therapeutic efficacy of sunitinib using [18F]FDG and [18F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma
10    52    1
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
10    41    1
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients

ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
8    37    1
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
16    28    1
Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications

Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications
15    34    1
Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling

Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling
12    31    1
The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer

The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer
11    41    1
Distinct expression and localization of the type II diacylglycerol kinase isozymes δ, η and κ in the mouse reproductive organs

Distinct expression and localization of the type II diacylglycerol kinase isozymes δ, η and κ in the mouse reproductive organs
10    28    1
Active behavior of triple-negative breast cancer with adipose tissue invasion: A single center and retrospective review

Active behavior of triple-negative breast cancer with adipose tissue invasion: A single center and retrospective review
11    37    1
Classification of bladder cancer cell lines according to regulon activity

Classification of bladder cancer cell lines according to regulon activity
17    49    1